Pagina's
Categorie archieven
- Corporate News (RSS) (15)
- Finance (RSS) (4)
- Geen categorie (RSS) (2)
- Human Resources (RSS) (3)
- Meetings (RSS) (4)
- R&D update (RSS) (4)
Blogberichten
- Okklo’s hematology asset will be further developed by Alveron Pharma (0)
- Okklo and SolAeroMed partner to develop cyclodextrins for cystic fibrosis treatment (0)
- Okklo Life Sciences B.V. and Sanquin sign commercialization agreement to enter IND enabling studies and clinical development. (0)
- Okklo receives RedMedTech Ventures funding and extends collaboration with Sanquin (0)
- Sanquin and Okklo Life Sciences enter R&D collaboration (0)
- Exclusive R&D collaboration BioAxis Research and Okklo Life Sciences (0)
- Okklo Life Sciences also supporting education in Life Sciences (0)
- Okklo Life Sciences rewarded 2nd KIEM grant (0)
- Vacancies in CycloN Hit ITN consortium (0)
- Collaboration & grant for innovation in rare diseases (0)
- Internship chemistry R&D (0)
- Internship Business Development & Strategy (0)
- Biomedica Summit, Aachen (D), June 2013 (0)
- New collaboration – BiCycle platform™ (0)
- okklo contributes to Gordon Research Conference on orphan diseases (0)
- okklo to attend the 12th MPS meeting in Noordwijkerhout, Netherlands (0)
- okklo life sciences now officially established at Life Science Park, Oss (0)
- Drug Delivery and Targeting – okklo in Iceland (0)
- okklo receives IPC grant (0)
- B4B meeting Frankfurt – okklo in rare diseases consortium (0)
- okklo life sciences into collaboration to combat MDR-TB (0)